Recent advances of immunohistochemistry for diagnosis of renal tumors

The recent classification of renal tumors has been proposed according to genetic characteristics as well as morphological difference. In this review, we summarize the immunohistochemical characteristics of each entity of renal tumors. Regarding translocation renal cell carcinoma (RCC), TFE3, TFEB and ALK protein expression is crucial in establishing the diagnosis of Xp11.2 RCC, renal carcinoma with t(6;11)(p21;q12), and renal carcinoma with ALK rearrangement, respectively. In dialysis‐related RCC, neoplastic cells of acquired cystic disease‐associated RCC are positive for alpha‐methylacyl‐CoA racemase (AMACR), but negative for cytokeratin (CK) 7, whereas clear cell papillary RCC shows the inverse pattern. The diffuse positivity for carbonic anhydrase 9 (CA9) is diagnostic for clear cell RCC. Co‐expression of CK7 and CA9 is characteristic of multilocular cystic RCC. CK7 and AMACR are excellent markers for papillary RCC and mucinous tubular and spindle cell carcinoma. CD82 and epithelial‐related antigen (MOC31) may be helpful in the distinction between chromophobe RCC and renal oncocytoma. WT1 and CD57 highlights the diagnosis of metanephric adenoma. The combined panel of PAX2 and PAX8 may be useful in the diagnosis of metastatic RCC.

[1]  A. Tanaka,et al.  Recent classification of renal epithelial tumors , 2014, Medical Molecular Morphology.

[2]  Y. Nagashima,et al.  Transition of organizational category on renal cancer. , 2013, Japanese journal of clinical oncology.

[3]  Y. Nagashima,et al.  Review of renal carcinoma with t(6;11)(p21;q12) with focus on clinical and pathobiological aspects. , 2013, Histology and histopathology.

[4]  L. Truong,et al.  PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison. , 2012, Archives of pathology & laboratory medicine.

[5]  J. Cheville,et al.  ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients , 2012, Modern Pathology.

[6]  D. Grignon,et al.  Multilocular Cystic Renal Cell Carcinoma: Similarities and Differences in Immunoprofile Compared With Clear Cell Renal Cell Carcinoma , 2012, The American journal of surgical pathology.

[7]  Y. Ishikawa,et al.  Identification of anaplastic lymphoma kinase fusions in renal cancer , 2012, Cancer.

[8]  C. Pan,et al.  Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. , 2012, Histology and histopathology.

[9]  N. Shikata,et al.  Utility of immunohistochemical analysis of KAI1, epithelial-specific antigen, and epithelial-related antigen for distinction of chromophobe renal cell carcinoma, an eosinophilic variant from renal oncocytoma , 2012, Medical Molecular Morphology.

[10]  L. Truong,et al.  Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? , 2012, Archives of pathology & laboratory medicine.

[11]  M. Seto,et al.  Genomic profiling of renal cell carcinoma in patients with end‐stage renal disease , 2012, Cancer science.

[12]  C. Pan,et al.  Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect. , 2012, Histology and histopathology.

[13]  P. Schirmacher,et al.  Molecular heterogeneity of TFE3 activation in renal cell carcinomas , 2012, Modern Pathology.

[14]  B. Alexiev,et al.  Renal-Cell Carcinomas in End-Stage Kidneys , 2012, International journal of surgical pathology.

[15]  T. Yoshino,et al.  Review of acquired cystic disease-associated renal cell carcinoma with focus on pathobiological aspects. , 2011, Histology and histopathology.

[16]  P. Russo,et al.  Role of Immunohistochemistry in the Evaluation of Needle Core Biopsies in Adult Renal Cortical Tumors: An Ex Vivo Study , 2011, The American journal of surgical pathology.

[17]  A. V. van Kessel,et al.  Genomic profiling of papillary renal cell tumours identifies small regions of DNA alterations: a possible role of HNF1B in tumour development , 2011, Histopathology.

[18]  J. Fletcher,et al.  ALK rearrangement in sickle cell trait‐associated renal medullary carcinoma , 2011, Genes, chromosomes & cancer.

[19]  S. Raimondi,et al.  Renal cell carcinoma with novel VCL–ALK fusion: new representative of ALK-associated tumor spectrum , 2011, Modern Pathology.

[20]  R. Shah,et al.  Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C‐kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics , 2011, Histopathology.

[21]  P. Argani,et al.  Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade. , 2010, American journal of clinical pathology.

[22]  J. Hicks,et al.  PAX8 (+)/p63 (−) Immunostaining Pattern in Renal Collecting Duct Carcinoma (CDC): A Useful Immunoprofile in the Differential Diagnosis of CDC Versus Urothelial Carcinoma of Upper Urinary Tract , 2010, The American journal of surgical pathology.

[23]  G. Kovacs,et al.  Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma , 2009, Histopathology.

[24]  Ximing J. Yang,et al.  Renal Tubulocystic Carcinoma Is Closely Related to Papillary Renal Cell Carcinoma: Implications for Pathologic Classification , 2009, The American journal of surgical pathology.

[25]  C. Pan,et al.  Immunohistochemical and molecular genetic profiling of acquired cystic disease‐associated renal cell carcinoma , 2009, Histopathology.

[26]  L. Insabato,et al.  Primary thyroid and thyroid-like follicular carcinoma of the kidney versus solitary metastatic carcinoma of the thyroid: a vexing issue , 2009, Virchows Archiv.

[27]  J. McKenney,et al.  Primary Thyroid-like Follicular Carcinoma of the Kidney: Report of 6 Cases of a Histologically Distinctive Adult Renal Epithelial Neoplasm , 2009, The American journal of surgical pathology.

[28]  R. Shah,et al.  Clear Cell Papillary Renal Cell Carcinoma: A Distinct Histopathologic and Molecular Genetic Entity , 2008, The American journal of surgical pathology.

[29]  Ximing J. Yang,et al.  Tubulocystic Carcinoma of the Kidney: Clinicopathologic and Molecular Characterization , 2008, The American journal of surgical pathology.

[30]  J. Srigley,et al.  Expression Analysis of Kidney-specific Cadherin in a Wide Spectrum of Traditional and Newly Recognized Renal Epithelial Neoplasms: Diagnostic and Histogenetic Implications , 2007, The American journal of surgical pathology.

[31]  L. Guillou,et al.  Alpha-methyl CoA racemase expression in renal cell carcinomas. , 2006, Human pathology.

[32]  S. Jung,et al.  Thyroid Follicular Carcinoma-like Tumor of Kidney: A Case Report With Morphologic, Immunohistochemical, and Genetic Analysis , 2006, The American journal of surgical pathology.

[33]  V. Reuter,et al.  Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma , 2006, Modern Pathology.

[34]  H. Moch,et al.  Spectrum of Epithelial Neoplasms in End-Stage Renal Disease: An Experience From 66 Tumor-Bearing Kidneys With Emphasis on Histologic Patterns Distinct From Those in Sporadic Adult Renal Neoplasia , 2006, The American journal of surgical pathology.

[35]  J. Srigley,et al.  Immunohistochemical Analysis of Mucinous Tubular and Spindle Cell Carcinoma and Papillary Renal Cell Carcinoma of the Kidney: Significant Immunophenotypic Overlap Warrants Diagnostic Caution , 2006, The American journal of surgical pathology.

[36]  L. Truong,et al.  Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms , 2005, Modern Pathology.

[37]  A. Folpe,et al.  Distribution of Cytokeratins and Vimentin in Adult Renal Neoplasms and Normal Renal Tissue: Potential Utility of a Cytokeratin Antibody Panel in the Differential Diagnosis of Renal Tumors , 2005, The American journal of surgical pathology.

[38]  C. Magi-Galluzzi,et al.  The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. , 2005, Clinics in laboratory medicine.

[39]  A. Haitel,et al.  Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study , 2005, Modern Pathology.

[40]  M. Ladanyi,et al.  Renal Carcinomas With the t(6;11)(p21;q12): Clinicopathologic Features and Demonstration of the Specific Alpha-TFEB Gene Fusion by Immunohistochemistry, RT-PCR, and DNA PCR , 2005, The American journal of surgical pathology.

[41]  M. Amin,et al.  An immunohistochemical approach to the differential diagnosis of renal tumors. , 2005, Seminars in diagnostic pathology.

[42]  P. Tamboli,et al.  Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray , 2004, Histopathology.

[43]  C. Pan,et al.  The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases , 2004, Histopathology.

[44]  P. Rehak,et al.  CD10 is a diagnostic and prognostic marker in renal malignancies , 2004, Histopathology.

[45]  Ximing J. Yang,et al.  Expression of Alpha-Methylacyl-CoA Racemase in Papillary Renal Cell Carcinoma , 2004, The American journal of surgical pathology.

[46]  T. Shuin,et al.  Review of renal oncocytoma with focus on clinical and pathobiological aspects. , 2003, Histology and histopathology.

[47]  M. Ladanyi,et al.  Aberrant Nuclear Immunoreactivity for TFE3 in Neoplasms With TFE3 Gene Fusions: A Sensitive and Specific Immunohistochemical Assay , 2003, The American journal of surgical pathology.

[48]  H. Enzan,et al.  Review of papillary renal cell carcinoma with focus on clinical and pathobiological aspects. , 2003, Histology and histopathology.

[49]  S. Kim,et al.  Immunohistochemical Profile of Common Epithelial Neoplasms Arising in the Kidney , 2002, Applied immunohistochemistry & molecular morphology : AIMM.

[50]  H. Enzan,et al.  Review of collecting duct carcinoma with focus on clinical and pathobiological aspects. , 2002, Histology and histopathology.

[51]  J. Cheville,et al.  Metanephric Adenoma, Nephrogenic Rests, and Wilms' Tumor: A Histologic and Immunophenotypic Comparison , 2001, The American journal of surgical pathology.

[52]  A. Scarpa,et al.  Parvalbumin Is Constantly Expressed in Chromophobe Renal Carcinoma , 2001, Modern Pathology.

[53]  A. Renshaw,et al.  Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. , 2000, The American journal of surgical pathology.

[54]  井上 享.  Genomic profiling of renal cell carcinoma in patients with end-stage renal disease , 2012 .

[55]  菅原 江美子.  Identification of anaplastic lymphoma kinase fusions in renal cancer : large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method , 2012 .

[56]  P. Tamboli,et al.  Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes. , 2011, Human pathology.

[57]  L. Truong,et al.  Immunohistochemical diagnosis of renal neoplasms. , 2011, Archives of pathology & laboratory medicine.

[58]  H. Enzan,et al.  Review of mucinous tubular and spindle-cell carcinoma of the kidney with a focus on clinical and pathobiological aspects. , 2005, Histology and histopathology.

[59]  U. Mansmann.  Genomic Profiling , 2005, Methods of Information in Medicine.

[60]  H. Enzan,et al.  Review of metanephric adenoma of the kidney with focus on clinical and pathobiological aspects. , 2003, Histology and histopathology.

[61]  H. Enzan,et al.  Review of chromophobe renal cell carcinoma with focus on clinical and pathobiological aspects. , 2003, Histology and histopathology.